- Filed
- Nov 7, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · Nov 4, 2025 | 39.5M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 40.56M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2025 | 41.69M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 43.92M sh |
| Shares Diluted | Q3 2025 · Sep 30, 2024 | 45.09M sh |
| Stock Repurchased | Q3 2025 · Sep 30, 2025 | $113.22M |
| Stock Repurchased | Q3 2025 · Sep 30, 2024 | $183.98M |
| Capex | Q3 2025 · Sep 30, 2025 | $85.89M |
| Capex | Q3 2025 · Sep 30, 2024 | $79.48M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2025 | $215.99M |
| Operating Cash Flow | Q3 2025 · Sep 30, 2024 | $232.08M |
| Long Term Debt | Q3 2025 · Sep 30, 2025 | $865.94M |
| Long Term Debt | Q3 2025 · Dec 31, 2024 | $864.28M |
| Cash And Equivalents | Q3 2025 · Sep 30, 2025 | $503.37M |
| Cash And Equivalents | Q3 2025 · Dec 31, 2024 | $505.88M |
| Stockholders Equity | Q3 2025 · Sep 30, 2025 | $1.8B |
| Stockholders Equity | Q3 2025 · Jun 30, 2025 | $1.84B |
| Stockholders Equity | Q3 2025 · Dec 31, 2024 | $1.81B |
| Stockholders Equity | Q3 2025 · Sep 30, 2024 | $1.75B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $1.87B |
| Stockholders Equity | Q3 2025 · Dec 31, 2023 | $1.89B |
| Current Liabilities | Q3 2025 · Sep 30, 2025 | $698.01M |
| Current Liabilities | Q3 2025 · Dec 31, 2024 | $899.65M |
| Total Liabilities | Q3 2025 · Sep 30, 2025 | $1.68B |
| Total Liabilities | Q3 2025 · Dec 31, 2024 | $1.89B |
| Current Assets | Q3 2025 · Sep 30, 2025 | $1.12B |
| Current Assets | Q3 2025 · Dec 31, 2024 | $1.27B |
| Total Assets | Q3 2025 · Sep 30, 2025 | $3.48B |
| Total Assets | Q3 2025 · Dec 31, 2024 | $3.7B |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Diluted | Q3 2025 · Sep 30, 2025 | $1.13 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$1.11 |
| Eps Diluted | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | −$0.09 |
| Eps Basic | Q3 2025 · Sep 30, 2025 | $1.13 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$1.11 |
| Eps Basic | Q3 2025 · Sep 30, 2024 | −$0.02 |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $54M |
| Sga Expense | Q3 2025 · Sep 30, 2025 | $154.98M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $52.42M |
| Sga Expense restated | Q3 2025 · Sep 30, 2024 | $150.43M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $15.4M |
| Rd Expense | Q3 2025 · Sep 30, 2025 | $47.76M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $15.26M |
| Rd Expense | Q3 2025 · Sep 30, 2024 | $49.82M |
| Net Income | Q3 2025 · Sep 30, 2025 | −$3.6M |
| Net Income | Q3 2025 · Sep 30, 2025 | $46.98M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$48.58M |
| Net Income | Q3 2025 · Sep 30, 2024 | −$1.04M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $28.43M |
| Operating Income | Q3 2025 · Sep 30, 2025 | $97.04M |
| Operating Income | Q3 2025 · Sep 30, 2024 | −$29.3M |
| Operating Income | Q3 2025 · Sep 30, 2024 | $35.13M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $53.15M |
| Cost Of Revenue | Q3 2025 · Sep 30, 2025 | $149.33M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $51.17M |
| Cost Of Revenue restated | Q3 2025 · Sep 30, 2024 | $147.08M |
| Revenue | Q3 2025 · Sep 30, 2025 | $363.71M |
| Revenue | Q3 2025 · Sep 30, 2025 | $1.04B |
| Revenue | Q3 2025 · Sep 30, 2024 | $353.58M |
| Revenue | Q3 2025 · Sep 30, 2024 | $988.87M |